Organigram to Acquire Germany’s Sanity Group in Major European Cannabis Push
President's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
OrganiGram Holdings ( (TSE:OGI) ) has shared an update.
Organigram has agreed to acquire all remaining shares of Berlin-based Sanity Group, one of Europe’s leading cannabis companies, for upfront consideration of €113.4 million and potential earnouts of up to €113.8 million tied to post-closing performance. The deal, funded through cash, a new credit facility and an expected C$65.2 million equity investment from BAT, will combine two market leaders across medical cannabis, recreational pilot programs and wellbeing products in the world’s two largest federally legal cannabis markets.
Sanity Group, founded in 2018, has rapidly scaled annual net revenue from €9 million in 2023 to €60 million in 2025 and operates Europe’s first two legal cannabis specialty stores under Swiss pilot projects. By adding Sanity’s strong German platform, planned entries into the U.K. and Poland, and existing business in Czechia, Organigram positions itself to sell larger volumes of higher-margin flower into Europe, deepen its supply-chain network, and extend its product IP into emerging legal cannabis markets, strengthening its competitive footing in a fast-growing European sector.
The most recent analyst rating on (TSE:OGI) stock is a Hold with a C$1.50 price target. To see the full list of analyst forecasts on OrganiGram Holdings stock, see the TSE:OGI Stock Forecast page.
Spark’s Take on TSE:OGI Stock
According to Spark, TipRanks’ AI Analyst, TSE:OGI is a Neutral.
The score is primarily weighed down by weak profitability and negative operating/free cash flow despite solid revenue growth and a low-leverage balance sheet. Technical indicators also lean bearish (below key moving averages and negative MACD), and valuation support is limited because the company is loss-making and has no dividend yield provided.
To see Spark’s full report on TSE:OGI stock, click here.
More about OrganiGram Holdings
Organigram Global Inc., listed on Nasdaq and the TSX, is a licensed cannabis producer focused on medical and adult-use markets. The company is pursuing a global pure-play cannabis strategy, targeting leadership positions in federally legal markets and leveraging product development and higher-margin cannabis flower exports to drive growth.
Average Trading Volume: 345,636
Technical Sentiment Signal: Strong Sell
Current Market Cap: C$235.1M
See more insights into OGI stock on TipRanks’ Stock Analysis page.
